157 related articles for article (PubMed ID: 12071)
1. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
Kluft C
Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
[TBL] [Abstract][Full Text] [Related]
3. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
Kluft C
Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
[No Abstract] [Full Text] [Related]
4. Fibrinolytic activity of salivary euglobulin fractions precipitated at pH 5.9 or 6.4 before and after mixing with blood.
Gersel-Pedersen N
Int J Oral Surg; 1980 Jun; 9(3):190-7. PubMed ID: 6777318
[TBL] [Abstract][Full Text] [Related]
5. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
Kluft C
Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
[TBL] [Abstract][Full Text] [Related]
6. Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria.
Bork K; Witzke G; Artmann K; Benes P; Böckers M; Kreuz W
Arch Dermatol Res; 1984; 276(6):375-80. PubMed ID: 6517610
[TBL] [Abstract][Full Text] [Related]
7. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
Jespersen J; Kluft C
Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and experimental studies of the influence of Cl-inactivator on the euglobulin clot lysis time (author's transl)].
Takeda S; Katoh H; Takaki A; Nouzuka Y; Ohsato K
Rinsho Ketsueki; 1979 Aug; 20(8):879-85. PubMed ID: 502003
[No Abstract] [Full Text] [Related]
9. The effect of dilution, pH and ionic strength of plasma on t-PA precipitation in euglobulin fraction.
Hong SY; Shin HK; Yang DH
Korean J Intern Med; 1992 Jul; 7(2):73-80. PubMed ID: 1306075
[TBL] [Abstract][Full Text] [Related]
10. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
Mikami A; Kohno M
Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
[TBL] [Abstract][Full Text] [Related]
11. [Immunochemical studies on proteinase inhibitor of co-precipitation after euglobulin fraction of plasma (author's transl)].
Miyatani K
Rinsho Byori; 1979; 27(1):57-9. PubMed ID: 311865
[No Abstract] [Full Text] [Related]
12. Electroimmunoassay of C1 inactivator and C4 in hereditary angioneurotic edema (HANE). A simplified diagnostic procedure.
Laurell AB; Mårtensson U; Sjöholm A
Clin Immunol Immunopathol; 1976 May; 5(3):308-13. PubMed ID: 1277590
[No Abstract] [Full Text] [Related]
13. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
Highsmith RF; Burnett CJ; Weirich CJ
J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
[No Abstract] [Full Text] [Related]
14. [A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].
Didkovskiĭ NA; Paskhina TS; Rabinovich SE; Nartikova VF; Dvoretskiĭ LI
Ter Arkh; 1989; 61(6):116-9. PubMed ID: 2799695
[TBL] [Abstract][Full Text] [Related]
15. [Study by means of enzymatic and immunochemical determination of Cl esterase inhibitor in 59 patients with hereditary angioneurotic edema].
Agostoni A; Marasini B; Cicardi M; Martignoni G; Brenna O
Boll Ist Sieroter Milan; 1977 Mar; 56(1):22-8. PubMed ID: 861073
[TBL] [Abstract][Full Text] [Related]
16. Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema.
Harpel PC; Hugli TE; Cooper NR
J Clin Invest; 1975 Mar; 55(3):605-11. PubMed ID: 123252
[TBL] [Abstract][Full Text] [Related]
17. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.
Quastel M; Harrison R; Cicardi M; Alper CA; Rosen FS
J Clin Invest; 1983 Apr; 71(4):1041-6. PubMed ID: 6833491
[TBL] [Abstract][Full Text] [Related]
18. Effects of dextran sulphate and flufenamic acid on euglobulin fibrinolytic activity of glass-treated or heated plasma.
Jenks RL; Astrup T
Haemostasis; 1980; 9(4):248-56. PubMed ID: 6156880
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
Kramer J; Katz Y; Rosen FS; Davis AE; Strunk RC
J Clin Invest; 1991 May; 87(5):1614-20. PubMed ID: 1902490
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.
Cicardi M; Igarashi T; Rosen FS; Davis AE
J Clin Invest; 1987 Mar; 79(3):698-702. PubMed ID: 3818946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
